Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma
This proof-of-concept study showed that the dispersion parameter of the first wave of contrast was 2.5 times higher in patients in whom FOLFIRINOX was effective, suggesting that this parameter could possibly be a reliable prediction tool.
Authors
- Mike J.P. de Jong (ORCID: https://orcid.org/0009-0007-7738-7206)
- Geke Litjens (ORCID: https://orcid.org/0000-0002-0436-9804)
- John J. Hermans (ORCID: https://orcid.org/0000-0001-9207-0548)
- Erwin-Jan M. van Geenen
- Tanya M. Bisseling (ORCID: https://orcid.org/0000-0001-7976-7949)
- T. H. Perik (ORCID: https://orcid.org/0000-0002-4194-787X)
- Foke van Delft (ORCID: https://orcid.org/0009-0008-5164-9148)
- Peter D. Siersema (ORCID: https://orcid.org/0000-0002-6940-8499)
- Fons van der Sommen (ORCID: https://orcid.org/0000-0002-3593-2356)
- Fer D W Radstake
Institutions
- Radboud University Nijmegen (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Isala (NL)
- Eindhoven University of Technology (NL)
Publication Details
- Journal
- Pancreatology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.pan.2025.01.011
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- KWF Kankerbestrijding